During the past decade, PinnacleHealth Cancer Center-Community Campus conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 11 clinical trials were completed, i.e. on average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PinnacleHealth Cancer Center-Community Campus" #1 sponsor was "SWOG Cancer Research Network" with 6 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Dune Medical Devices" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PinnacleHealth Cancer Center-Community Campus" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator, "Radiation Therapy Oncology Group" with 1 trials as a collaborator and "Roche-Genentech" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "PinnacleHealth Cancer Center-Community Campus" are "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Breast Cancer" (2 trials), "Adult Anaplastic Astrocytoma" (1 trials) and "Adult Anaplastic Oligodendroglioma" (1 trials). Many other conditions were trialed in "PinnacleHealth Cancer Center-Community Campus" in a lesser frequency.

Most popular intervention types in "PinnacleHealth Cancer Center-Community Campus" are "Drug" (11 trials), "Other" (9 trials), "Biological" (5 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Docetaxel" (3 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "PinnacleHealth Cancer Center-Community Campus" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "PinnacleHealth Cancer Center-Community Campus". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in PinnacleHealth Cancer Center-Community Campus, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in PinnacleHealth Cancer Center-Community Campus, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".